Rafaela N. Barcelos

Rafaela N. Barcelos

Auto-generated profile, based on publicly available information

Rafaela N. Barcelos

Centro de Doenças da Tireoide e Laboratório de Endocrinologia Molecular e Translacional, Disciplina de Endocrinologia e Metabologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CNCláudia C. D. Nakabashi
Cláudia C. D. Nakabashi
RBRosa Paula M. Biscolla
Rosa Paula M. Biscolla
TKTeresa S. Kasamatsu
Teresa S. Kasamatsu
TTTeresinha T. Tachibana
Teresinha T. Tachibana
RBRafaela N. Barcelos
Rafaela N. Barcelos
JVJosé Gilberto H. Vieira
José Gilberto H. Vieira
In the last decade, data published stressed the role of highly-sensitive thyroglobulin (Tg) assays in the follow-up of differentiated thyroid carcinoma (DTC) patients. The present study describes a new, highly-sensitive Tg assay, compares it with an available commercial assay, and validates it in the follow-up of DTC patients. The immunofluorometric high-sensitivity Tg assay is based on monoclonal and polyclonal antibodies produced at our laboratories. It was validated in 100 samples of 87 patients with DTC submitted to total thyroidectomy, 87% of whom also received radioiodine. For correlation, all samples were also tested using a commercial Tg assay (Beckman Access) with functional sensitivity (FS) of 0.1 ng/mL. The new method showed FS of 0.3 ng/mL. The correlation between the two methods was good (r = 0.74; p < 0.0001). The diagnostic sensitivity was 88.9%, and it was increased to 100% when combined with neck US. This new, high-sensitivity Tg assay presented a good correlation with Beckman Access assay and with the clinical outcome of the patients. The continuous availability of a validated assay is an additional advantage for long term follow-up of DTC patients.

21 June 2023 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RBRafaela N. Barcelos
Rafaela N. Barcelos
Cleber Pinto CamachoCleber Pinto Camacho
Cleber Pinto Camacho
MMMaria da Conceição de O. C. Mamone
Maria da Conceição de O. C. Mamone
EIElza S. Ikejiri
Elza S. Ikejiri
FVFelipe A. B. Vanderlei
Felipe A. B. Vanderlei
JMJoão Roberto M. Martins
João Roberto M. Martins
Objective: The risk of malignancy and diagnostic accuracy of fine-needle aspiration biopsy (FNAB) of thyroid nodules (TN) with diameters ≥ 3-4 cm remains controversial. However, some groups have indicated surgical treatment in these patients regardless of the FNAB results. We aimed to evaluate the diagnostic accuracy of the FNAB in systematically resected ≥4 cm TN and if the risk of malignancy is higher in these patients. Subjects and methods: We retrospectively evaluated 138 patients (142 nodules) with TN with [...] ABSTRACT Objective: The risk of malignancy and diagnostic accuracy of fine-needle aspiration biopsy (FNAB) of thyroid nodules (TN) with diameters ≥ 3-4 cm remains controversial. However, some groups have indicated surgical treatment in these patients regardless of the FNAB results. We aimed to evaluate the diagnostic accuracy of the FNAB in systematically resected ≥4 cm TN and if the risk of malignancy is higher in these patients. Subjects and methods: We retrospectively evaluated 138 patients (142 nodules) with TN with